Lurasidone
- In silico1
Latest
2 in 12 monthsFigshare
GHS-CVRAI: A Receptor-Resolved Cardiovascular Risk Amplification Index for Antipsychotic Prescribing Across Psychiatric Disorders
Preprint: computational studyBiomarkers
Related
- 13-RECEPTORGENESET1
- Cellular senescence1
- GHS-CVRAI1
- Glial-Hematopoietic-Senescence Cardiovascular Risk Amplification Index1
- Inflammation1
- Major depressive disorder1
- Antipsychotics1
- Aripiprazole1
- Bipolar disorder1
- Cardiovascular disease1
- Clonal hematopoiesis of indeterminate potential1
- Low-density lipoprotein cholesterol1
- Obsessive-compulsive disorder1
- Psychiatric disorder1
- Quetiapine1
- Risperidone1